BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Stereotaxis, Inc. (STXS) Receives Delisting Warning From Nasdaq


3/26/2013 10:18:21 AM

Medical device maker Stereotaxis Inc. received a notification on March 20 from the Nasdaq Stock Market that the company was not in compliance with the market's rule that it must have $50 million in total assets and total revenues for the most recently completed fiscal year or for two of the last three most recently completed fiscal years. In addition, according to a Nasdaq letter, Stereotaxis does not comply with an alternative listing rule requirement for continued listing on the Nasdaq Global Market because the company’s stockholders’ equity is less than $10 million and the market value of listed securities of the company is less than $50 million. In its notice, Nasdaq stated that the company may provide a plan to regain compliance with the continued listing requirements by May 6. If Nasdaq accepts the plan, it can grant an extension of up to 180 calendar days from the date of the letter (through Sept. 16).


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES